On my blog (bkoffman.blogspot.com), I have commented on the extensive black box warnings on the label for idelalisib or ZYDELIG that is a stark contrast to no black box for ibrutinib, not that IMBRUVICA doesn't come with its own set of cautions and concerns.
Labels and package inserts often change as we learn more and new indications and/or problems are added to the drug's profile.
I try to give some perspective on how to approach these issues.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
